NEW YORK (GenomeWeb) – Oxford Nanopore Technologies yesterday provided several updates on its technology development and commercialization plans, including a new MinIon flow cell, called Flongle, for clinical diagnostic applications.

Clive Brown, the company's chief technology officer, presented the updates last night at the firm's user meeting in London. While his talk was not public, Oxford Nanopore disseminated much of the information through a series of Twitter messages.